Aurora Kinase Inhibitors - Rising Stars in Cancer Therapeutics?
Altaf A. Dar(Vanderbilt University Medical Center), Wael El‐Rifai(Vanderbilt University Medical Center)
Cited by 248
Related Papers
Loss of TFF1 is associated with activation of NF-κB–mediated inflammation and gastric neoplasia in mice and humans
|Journal of Clinical Investigation|2011|123
Aurora Kinase A Promotes Inflammation and Tumorigenesis in Mice and Human Gastric Neoplasia
|Gastroenterology|2013|117
Aurora Kinase A Inhibition Leads to p73-Dependent Apoptosis in p53-Deficient Cancer Cells
|Cancer Research|2008|117
Frequent overexpression of Aurora Kinase A in upper gastrointestinal adenocarcinomas correlates with potent antiapoptotic functions
|Cancer|2008|110
Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9
|Scientific Reports|2020|89